Corporate News

Cambridge Nutritional Sciences plc (AIM:CNSL), the specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition, announces that on 22 May 2025 sentencing occurred in respect of legal proceedings brought against its wholly-owned subsidiary Omega Diagnostics Limited by the Health & Safety Executive, in relation to four historical breaches of health and safety regulations in 2018. The breaches relate to Omega South West, a company previously owned by Omega Diagnostics Limited. Omega South West was sold in 2018 and therefore is no longer a trading entity of the Company.

In March 2025, Omega Diagnostics entered guilty pleas in respect of the four identified breaches. At yesterday's sentencing hearing the court found that there was no deliberate breach or flagrant disregard for the law, found no aggravating factors, and found substantial mitigating factors including: no previous convictions, good health and safety record, full cooperation, sincere regret expressed, and breaches over only a narrow window of time.  The court also gave full credit for early guilty pleas. The court imposed a total fine of £0.035m in respect of all charges.

With this outcome, the matter is now formally concluded with no further liability or legal action expected in relation to this case.

The financial impact of the fine has been fully provided for within the Group's existing provisions. As such, there will be no material effect on the Company's financial performance for the current or future financial years. The outcome will be appropriately disclosed in the Group's forthcoming Annual Report and Financial Statements.

The Board reaffirms its commitment to upholding the highest standards of compliance and corporate responsibility across all of its operations.

Following the conclusion of this matter, the Company intends to make a trading update for the year ended 31 March 2025 shortly.

Contacts: 

About Cambridge Nutritional Sciences plc

Cambridge Nutritional Sciences plc (AIM: CNSL) is a specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition.